Fibronectin (FN) Cooperated with TLR2/TLR4 Receptor to Promote Innate Immune Responses of Macrophages Via Binding to Integrin β1
Overview
Authors
Affiliations
Macrophages could adhere to extracellular matrix molecules(ECM) to induce the expression of pro-inflammatory mediators and phagocytosis that contribute to the pathogenesis of pulmonary infection diseases. Fibronectin (FN) is a large glycoprotein capable of interacting with various ECM molecules produced by a variety of cell types and involved in cell attachment and chemotaxis. However, it is unknown whether FN regulates the expression of pro-inflammatory mediators and phagocytosis of macrophages in the injured lung tissue. Here, we investigated the interaction between FN and integrin β1 in macrophages, which promotes toll-like receptor 2/4 (TLR2/TLR4) signaling pathways to enhance expression of pro-inflammatory mediators and phagocytosis by macrophages. Our results show that lipopolysaccharide (LPS), lipoteichoic acid (LTA) and peptidoglycan (PGN) significantly increase FN expression of macrophages; FN substantially enhances interleukin 6 (IL-6), tumor necrosis factor-α (TNFα), ras-related C3 botulinum toxin substrate 1/2 (Rac1/2), and cell division control protein 42 homolog (Cdc42) expression and phagocytosis of macrophages. However, FN could not enhance pro-inflammatory cytokines and phagocytosis of macrophages induced by LPS and PGN in integrin β1-/- macrophages. Furthermore, applied integrin β1 blocking peptide abrogated the effects that FN promotes innate immune responses of macrophages to LPS and PGN. Those data indicated that the enhanced pro-inflammatory mediators and phagocytosis of macrophages by FN-integrin β1 signal was through co-operating with TLR2/TLR4 signaling. This study suggests that FN play an essential role in the pathogenesis of pulmonary infection disease.
Xu C, Wei J, Song D, Zhao S, Hou M, Fan Y JCI Insight. 2024; 9(22).
PMID: 39361424 PMC: 11601898. DOI: 10.1172/jci.insight.174836.
Dovrolis N, Valatas V, Drygiannakis I, Filidou E, Spathakis M, Kandilogiannakis L Biomedicines. 2024; 12(8).
PMID: 39200138 PMC: 11351973. DOI: 10.3390/biomedicines12081674.
Bonadio J, Bashiri G, Halligan P, Kegel M, Ahmed F, Wang K Adv Drug Deliv Rev. 2024; 209:115303.
PMID: 38588958 PMC: 11111362. DOI: 10.1016/j.addr.2024.115303.
Sun H, Mao J, Wang Y, Fan Z, Yuan C, Wang X Comput Struct Biotechnol J. 2022; 20:5966-5977.
PMID: 36382199 PMC: 9641012. DOI: 10.1016/j.csbj.2022.10.043.
Poulis N, Martin M, Hoerstrup S, Emmert M, Fioretta E Front Cardiovasc Med. 2022; 9:952178.
PMID: 36176991 PMC: 9513146. DOI: 10.3389/fcvm.2022.952178.